GlassScriptPhysician profile
Scott Alan Walter
NPI 1609293067
$99,119.50
in general payments reported to CMS, 2019-2025
28 companies · $5,990 in 2025
The $5,990 reported for 2025 was more than what 90% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $694 · 2021: $1,058 · 2022: $461 · 2023: $12K · 2024: $78K · 2025: $5,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $75K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $2,078 · Education: $115 · Travel and Lodging: $99.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $75,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,800.00 |
| Food and Beverage | $2,077.58 |
| Education | $115.26 |
| Travel and Lodging | $99.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $75,257.50 | 2020-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $19,168.76 | 2019-2025 | Aklief, Nemluvio |
| Genzyme Corporation | $661.18 | 2019-2025 | |
| Abbvie INC. | $592.23 | 2019-2025 | |
| Leo Pharma INC. | $456.33 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $375.19 | 2019-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $336.26 | 2020-2024 | Ilumya, Winlevi |
| Lilly USA, LLC | $293.08 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Incyte Corporation | $258.66 | 2022-2025 | Opzelura |
| Vyne Pharmaceuticals INC. | $210.89 | 2020-2021 | |
| Janssen Biotech, INC. | $190.40 | 2020-2025 | Tremfya, Stelara, Simponi Aria |
| Pfizer INC. | $188.31 | 2020-2024 | |
| Dermavant Sciences, INC. | $174.88 | 2023-2024 | Vtama |
| Dermira, INC. | $114.76 | 2019-2021 | |
| Epi Health, LLC | $106.02 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $97.33 | 2019 | |
| Celgene Corporation | $88.84 | 2019 | |
| Almirall LLC | $88.12 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $83.62 | 2019-2025 | |
| Ucb, INC. | $80.40 | 2021-2024 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $71.49 | 2022-2023 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.25 | 2019-2020 | |
| Organon LLC | $42.01 | 2025 | Vtama |
| Neurotech Pharmaceuticals, INC. | $40.00 | 2025 | |
| Prugen, INC. Pharmaceuticals | $34.39 | 2019 | |
| Kyowa Kirin, INC. | $29.74 | 2025 | |
| Krystal Biotech INC | $16.18 | 2025 | Vyjuvek |
| Merck Sharp & Dohme LLC | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.